Article
Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.
Breast cancer research and treatment - 1 Jan 2014
Radovich Milan, Clare Susan E, Atale Rutuja, Pardo Ivanesa, Hancock Bradley A, Solzak Jeffrey P, Kassem Nawal, Mathieson Theresa, Storniolo Anna Maria V, Rufenbarger Connie, Lillemoe Heather A, Blosser Rachel J, Choi Mi Ran, Sauder Candice A, Doxey Diane, Henry Jill E, Hilligoss Eric E, Sakarya Onur, Hyland Fiona C, Hickenbotham Matthew, Zhu Jin, Glasscock Jarret, Badve Sunil, Ivan Mircea, Liu Yunlong, Sledge George W, Schneider Bryan P
Abstract excerpt
Triple-negative breast cancers (TNBCs) are a heterogeneous set of tumors defined by an absence of actionable therapeutic targets (ER, PR, and HER-2). Microdissected normal ductal epithelium from healthy volunteers represents a novel comparator to reveal insights into TNBC heterogeneity and to inform drug development. Using RNA-sequencing data from our institution and The Cancer Genome Atlas (TCGA) we compared the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
